IP Verse

Fhoffmann La Roche competitive analysis

Explore patent oppositions filed by Fhoffmann La Roche against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 2, 2026

Patent Number	Title	Applicant	Opposition Date
EP2917229	Antibodies And Fragments Thereof Raised Against The Alpha-3 Domain Of Hla-G Protein, Methods And Means For Their Preparation, And Uses Thereof	INVECTYS	Oct 8, 2020
EP2864479	Modulation Of Ube3A-Ats Expression	BAYLOR COLLEGE OF MEDICINE	May 14, 2019
EP2819701	Immunotherapeutic Molecules And Uses	THE UNIVERSITY OF BIRMINGHAM	Apr 23, 2019
EP2707383	Methods Of Preventing And Removing Trisulfide Bonds	BIOGEN IDEC MA	Jan 4, 2019
EP2188371	Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors	WYETH	Sep 19, 2018
EP2802607	Dual Antigen-Induced Bipartite Functional Complementation	JULIUS MAXIMILIANS UNIVERSITT WRZBURG	Jul 4, 2018
EP3013849	Purification Process For Monoclonal Antibodies	CADILA HEALTHCARE	Jun 12, 2018
EP2906683	Mammalian Cell Culture Processes For Protein Production	BRISTOL MYERS SQUIBB	Feb 27, 2018
EP2637670	Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains	AMGEN	Dec 1, 2017

Discover the latest PTAB cases involving Fhoffmann La Roche, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Fhoffmann La Roche with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 2, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
FHOFFMANN LA ROCHE	9	-	-	-
AMGEN	8	151	8	11
AMGEN RESEARCH MUNICH	-	32	-	-
BAYLOR COLLEGE OF MEDICINE	-	10	2	-